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Introduction {#sec1}
============

The eukaryotic RNA exosome is a conserved ribonuclease complex that controls the quantity and quality of a large number of RNAs. Exosome-mediated RNA degradation leads to the elimination of nuclear and cytoplasmic transcripts in turnover and quality control pathways or to partial trimming of RNA precursors in processing pathways (reviewed in [@bib9], [@bib22], [@bib29], [@bib30], [@bib33], [@bib42]). The core complex of the RNA exosome was originally discovered from genetic and biochemical analyses in budding yeast ([@bib39]) and has since been characterized at the molecular and structural level (reviewed in [@bib24], [@bib34]). Orthologs have also been identified in other eukaryotes and have been linked to Mendelian diseases in the human population ([@bib2], [@bib17]).

The yeast exosome core complex is formed by ten different proteins. Only a single subunit (Rrp44, also known as Dis3) is catalytically active ([@bib15], [@bib31]). The other nine core subunits (Exo~9~) form a cylindrical structure that threads RNA substrates to the Rrp44 exoribonuclease site ([@bib6], [@bib31], [@bib34], [@bib56]). Yeast Exo~10~ is present in the nucleus as well as in the cytoplasm but binds compartment-specific cofactors. In the nucleus, the exosome associates with an additional ribonuclease complex (Rrp6-Rrp47), an RNA helicase (Mtr4), and a small protein (Mpp6) to form a 14-subunit assembly ([@bib8], [@bib45]). In the cytoplasm, the exosome functions together with the Ski2-Ski3-Ski8-Ski8 (Ski) complex, a tetrameric assembly centered at an Mtr4-like RNA helicase (Ski2) ([@bib3], [@bib7], [@bib21]). Orthologs of these exosome cofactors are well conserved in eukaryotes ([@bib43], [@bib8], [@bib42]), and several are mutated in human diseases (reviewed in [@bib17], [@bib49]).

An additional cofactor, Ski7, bridges the interaction between the exosome and Ski complexes in *S. cerevisiae* ([@bib4], [@bib21], [@bib52], [@bib54]). The N-terminal exosome-binding and Ski-binding domains of Ski7 are required for all known exosome functions in the cytoplasm, including mRNA turnover and quality-control pathways ([@bib4], [@bib42], [@bib53]. The C-terminal GTPase-like domain of Ski7 has instead a specific role in nonstop decay (NSD) ([@bib53]). NSD is one of the quality-control pathways that monitors the process of mRNA translation: it eliminates defective transcripts where the absence of in-frame termination codons causes ribosomes to stall upon translating the 3′ poly(A) tail (reviewed in [@bib23], [@bib26], [@bib32], [@bib47]). *S. cerevisiae* Ski7 is a paralogue of the ribosome recycling factor Hbs1. Hbs1 functions in no-go decay (NGD), another translational quality-control pathway that targets and degrades transcripts with ribosomes stalled in the coding region or in the 3′ untranslated region ([@bib13], [@bib20]; and reviewed in [@bib23], [@bib32], [@bib47]). Yeast Hbs1 and Dom34 have also been recently implicated in NSD ([@bib51]).

The *SKI7* and *HBS1* paralogous genes originated from an ancestral genome duplication event in budding yeast ([@bib36]). The Ski7 and Hbs1 proteins comprise a similar translational GTPase-like domain ([@bib27]) and are expected to share similarities in recognizing stalled ribosomes ([@bib53]). However, they diverge in their activities (GTP binding versus GTP hydrolysis), mRNA targets (nonstop versus no-go mRNAs), and interacting proteins (exosome-Ski versus Dom34). Another conspicuous difference is that Hbs1 is conserved across eukaryotes while Ski7 orthologs have only been identified in a subset of fungal species ([@bib36]). Although Ski7 is currently assumed to be a specialized protein in yeasts, several observations argue against such evolutionary restriction. First, given that the exosome and Ski complexes are conserved from yeast to human, it is reasonable to expect that a Ski7-like cofactor would bridge their interaction also in higher eukaryotes. Second, NSD is not limited to yeast but also exists in mammalian cells, where it depends on HBS1-DOM34 as well as exosome and SKI proteins ([@bib41]). In this work, we set out to visualize how the yeast exosome interacts with Ski7, and based on the structural information, we identified isoform 3 of HBS1L as the human counterpart of Ski7.

Results and Discussion {#sec2}
======================

Identification and Structure Determination of a Minimal Exosome-Ski7 Complex {#sec2.1}
----------------------------------------------------------------------------

Ski7 mediates the interaction between the RNA degrading exosome and the Ski complex in vivo ([@bib4]) and in vitro (see [Figure S1](#mmc1){ref-type="supplementary-material"}A available online). Coimmunoprecipitation studies from yeast strains expressing different tagged versions of Ski7 have identified two separate domains in the N-terminal region as responsible for binding the Ski and exosome complexes ([@bib4]). We recapitulated the interactions in vitro with purified recombinant proteins and more precisely defined the domain boundaries within Ski7. Using a combination of secondary structure prediction, limited proteolysis, and pull-down assays ([Figure S1](#mmc1){ref-type="supplementary-material"}B), we mapped the Ski2-Ski3-Ski8-interacting domain of Ski7 at residues 1--105 and the Exo~9~-interacting domain at residues 116--235 ([Figure 1](#fig1){ref-type="fig"}A). Both domains are predicted to contain sparse secondary structure elements.

We proceeded to crystallize a yeast exosome core bound to the interacting domain of Ski7. To this end, we used a catalytically inactive 10-subunit exosome complex where the Rrp44 subunit had been mutated to impair the exonuclease and endonuclease active sites (D551N, D171N substitutions), hereafter referred to as Exo~10~ ([@bib6], [@bib31], [@bib34]). Based on the approach we have previously used for crystallizing an exosome core bound to the nuclear cofactor Rrp6 ([@bib34]), we added an RNA substrate featuring a tetra-loop at the 5′ end and a single-stranded extension of 28 ribonucleotides at the 3′ end (U~loop-28~). The Exo~10~-U~loop-28~ complex bound to Ski7 residues 116--235 yielded crystals, but the hair-like needles were unsuitable for diffraction studies. To promote additional crystal packing interactions, we followed a protein engineering strategy ([@bib10]) and fused T4 lysozyme (T4L) to the C terminus of the construct. Ski7~116-235~-T4L yielded thicker needles of the complex that diffracted to 4.2 Å resolution. Structure determination by molecular replacement and model building suggested that truncating the C terminus of Ski7 and thus shortening the linker to T4L could improve crystal quality ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Indeed, the corresponding exosome complex with a truncated Ski7 domain (residues 116--225, Ski7~exo~) fused to T4L showed improved diffraction properties ([Figure 1](#fig1){ref-type="fig"}A). The crystal structure of *S. cerevisiae* Exo~10~-Ski7~exo~T4L-U~loop-28~ (hereafter referred to as Exo~10~-Ski7-RNA) was determined and refined to 2.65 Å resolution with *R*~free~ of 25.9% *R*~factor~ of 21.5% and good stereochemistry ([Figure 1](#fig1){ref-type="fig"}B and [Table 1](#tbl1){ref-type="table"}).

Exo~10~--Ski7--RNA Complex: The Exosome Core {#sec2.2}
--------------------------------------------

The 10-subunit exosome core in the Ski7-bound complex is overall similar to that observed in Rrp6-bound complexes ([@bib34], [@bib35], [@bib56]) ([Figures 1](#fig1){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}A). In particular, the ring formed by the six RNase PH-like proteins (Rrp41, Rrp45, Rrp46, Rrp43, Mtr3, and Rrp42) superposes well with that observed in other exosome structures (root-mean-square deviation \[rmsd\] of less than 1.22 Å over all α-carbon atoms) ([@bib35], [@bib34], [@bib56]). At the top of the RNase PH-like subunits, the three so-called cap proteins (Rrp4, Rrp40, and Csl4) form an upper ring that closes around part of the RNA 5′ tetra-loop ([@bib34]). Near the bottom of the RNase PH-like subunits, the Rrp44 nuclease is in a closed conformation reminiscent of that found in an exosome complex crystallized before in the presence of a long RNA in the central channel ([@bib34]) ([Figure S2](#mmc1){ref-type="supplementary-material"}A).

Despite the overall similarity with previous structures, there are several differences. Starting from the top of the complex, a loop of Csl4 (residues 158--200) undergoes a large conformational change when compared to Rrp6-bound structures ([@bib34], [@bib35], [@bib56]): instead of protruding from the outer surface of the exosome, it lines the inner cavity of the complex, where it approaches the RNA in the central channel ([Figures 1](#fig1){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}B). The outward facing conformation of this loop observed in Rrp6-bound complexes would not be compatible with the Ski7-bound complex because of steric clashes with the N terminus of Rrp43 ([Figure S2](#mmc1){ref-type="supplementary-material"}C). However, whether this loop influences the specific activity of the nuclear and cytoplasmic exosomes in *S. cerevisiae* is currently unclear, as we could not detect obvious changes with the assays and substrates we have tested.

Another significant difference in comparison to earlier structures is that one of the three OB-fold domains of Rrp44 (CSD1) is shifted away from the RNase PH-like ring by about 10 Å. In turn, the opposite loops from Rrp42 and Rrp43 are disordered (residues 159--169 and 250--270, respectively). The alternative conformation of CSD1 changes the shape of the internal RNA-binding channel in this part of the complex, and in parallel the ribonucleotide chain also deviates in its path ([Figures 1](#fig1){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}D). Although the movement of CSD1 appears to be due to crystal packing rather than to Ski7 binding, it highlights the conformational plasticity of the Rrp44 subunit and of how RNA substrates can thread through it. Interestingly, such a movement might also open an alternative RNA path from the central channel to the endonuclease site of the PIN domain ([Figures 1](#fig1){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}D). This potential RNA path would be consistent with previous biochemical data supporting the presence of a channel-dependent path to the exosome endonuclease site ([@bib14], [@bib55]).

Finally, a difference with previous structures is observed at the RNA 3′ end, where density for one additional ribonucleotide is present ([Figures 1](#fig1){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}E). It appears that the RNA substrate continues with one nucleotide beyond the inactive exonuclease site (D551N), toward the solvent. This position likely reflects the exit route taken by the cleaved 3′ end nucleotide that would be produced and expelled by a wild-type active complex.

Exo~10~--Ski7--RNA Complex: The Cytoplasmic Cofactor Ski7 {#sec2.3}
---------------------------------------------------------

The N-terminal region of Ski7 is natively unfolded in solution ([Figure S3](#mmc1){ref-type="supplementary-material"}A) but adopts well-defined secondary structure elements when bound to Exo~10~ ([Figure 1](#fig1){ref-type="fig"}B). Ski7~exo~ folds into four helices (α1--α4) connected by extended linkers. Most of the polypeptide chain has well-ordered electron density ([Figure S3](#mmc1){ref-type="supplementary-material"}B), with the exception of residues 142--147 and residues 159--179 in the linkers connecting Ski7~exo~ helices α1-α2 and α2-α3, respectively. Ski7~exo~ binds at the upper half of the exosome core, where it interacts with the cap protein Csl4 and with the RNase PH-like proteins Mtr3 and Rrp43 ([Figure 2](#fig2){ref-type="fig"}A). In the structure, Ski7~exo~ helix α4 directly continues into the T4L molecule that was artificially fused to it for crystallization purposes. T4L is partially ordered at the top of the exosome and interacts with the cap protein Rrp4. With hindsight, the T4L engineering strategy not only contributed an additional crystal contact but also likely stabilized the cap proteins via a contact to Rrp4 ([Figure S1](#mmc1){ref-type="supplementary-material"}C). The position of T4L in the structure is far from Ski7-exosome interaction sites ([Figures 1](#fig1){ref-type="fig"}B and [2](#fig2){ref-type="fig"}A), and as such it will not be discussed further.

Ski7 Wraps around Csl4, Rrp43, and Mtr3 with Extensive Interactions {#sec2.4}
-------------------------------------------------------------------

Ski7~exo~ wraps around the exosome covering about 3,150 Å^2^ of its accessible surface area (1,625 Å^2^ of Csl4, 870 Å^2^ of Rrp43, and 660 Å^2^ of Mtr3), as calculated with the PISA server ([@bib28]). Starting from the N terminus, the α1 helix of Ski7~exo~ docks into a conserved hydrophobic pocket present on the side of the Csl4 N-terminal domain (patch 1) ([Figure 2](#fig2){ref-type="fig"}B). Here, hydrophobic side chains of Ski7 (Leu121^Ski7^, Trp125^Ski7^, Ile128^Ski7^, Met131^Ski7^) engage in van der Waals interactions with Csl4 ([Figure 2](#fig2){ref-type="fig"}B). Following the first helix, an extended segment with hydrophobic residues (e.g., Tyr134^Ski7^) stretches over the surface of Mtr3, connecting to the second helix ([Figure 2](#fig2){ref-type="fig"}B). The short α2 helix of Ski7~exo~ wedges into a hydrophobic cleft formed at the junction between Mtr3 and Rrp43 (patch 2) ([Figure 2](#fig2){ref-type="fig"}C). Here, the interaction is mediated by a cluster of apolar side chains (including Phe149^Ski7^, Phe151^Ski7^, Phe154^Ski7^, Ile155^Ski7^, Ile156^Ski7^) ([Figure 2](#fig2){ref-type="fig"}C). After a disordered segment, the linker connecting to the third helix coils around Rrp43 and projects hydrophobic residues (Leu186^Ski7^, Leu187^Ski7^, Ile189^Ski7^, Phe190^Ski7^, Pro192^Ski7^) into a cleft formed at the junction with the Csl4 C-terminal domain (patch 3) ([Figure 2](#fig2){ref-type="fig"}D). Finally, Ski7~exo~ helix α3 and the tip of helix α4 bind onto a conserved hydrophobic surface at the side of the Csl4 C-terminal domain (via Leu195^Ski7^, Ala203^Ski7^, Phe207^Ski7^, Pro212^Ski7^) (patch 4) ([Figure 2](#fig2){ref-type="fig"}E).

The interaction between Ski7 and the exosome is overall dominated by hydrophobic contacts, but there are additional polar interactions (e.g., Asn132^Ski7^ at patch 1, Thr152^Ski7^ at patch 2, Glu185^Ski7^ at patch 3 and Asp213 ^Ski7^, Asp214^Ski7^, Gln217^Ski7^ at patch 4). With hindsight, the recently reported crosslinking-mass spectrometry data on the Ski7-exosome interaction support well-ordered parts of the complex structure (crosslinks between Lys180^Ski7^ and Lys45^Rrp43^, and Lys181^Ski7^ and Lys45^Rrp43^) ([Figure S3](#mmc1){ref-type="supplementary-material"}C) ([@bib46]). Multiple crosslinks observed beyond the boundaries of our crystallization construct might have been caused by the collapse of flexible regions of Ski7 upon crosslinking treatment, but are consistent with the overall directionality of the Ski7 polypeptide on the exosome.

Effect of Specific Structure-Based Mutations In Vitro and In Vivo {#sec2.5}
-----------------------------------------------------------------

Based on the structural analysis, we engineered a series of substitutions at the largest interaction hotspots of Ski7~exo~ and tested the ability of the mutants to bind the exosome in pull-down assays with purified proteins. Mutations of Ski7 residues at patch 1 (Trp125Asp, Ile128Asp, or Ski7~exomut-1~), patch 2 (Phe149Asp, Phe151Asp, Phe154Asp, or Ski7~exomut-2~), or patch 3 (Ile189Asp, Phe190Asp or Ski7~exomut-3~) were not sufficient to individually impair the interaction with Exo~9~ ([Figure 2](#fig2){ref-type="fig"}F, lanes 8--11). Exo~9~ binding was disrupted in vitro only when impairing two interaction hotspots simultaneously (Ski7~exomut-23~, with 5 combined mutations at patches 2 and 3) ([Figure 2](#fig2){ref-type="fig"}F, lane 12). Similarly mutating a binding surface in patch 4 on Csl4 (Trp272Glu, Phe292Glu, Asn250Ala or Csl4~exomut-4~) did only disrupt interaction in combination with one of the Ski7 mutations ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Albeit qualitative, these assays suggested the presence of a high-affinity interaction between Ski7 and the exosome. Indeed, quantitative measurements by microscale thermophoresis (MST) revealed a dissociation constant in the low nanomolar range (*K*~d~ ∼5 nM, [Figure S4](#mmc1){ref-type="supplementary-material"}A). When impairing a single patch in Ski7~exomut-1~, the binding affinity decreased 10-fold but remained relatively high (*K*~d~ 50 nM, [Figure S4](#mmc1){ref-type="supplementary-material"}A).

Next, we tested the effect of Ski7 mutants in complementation assays in yeast. We integrated wild-type *SKI7*, *ski7*~Δ*N*~, *ski7*~Δ*exo*~ (lacking the entire exosome-binding domain), or *ski7*~*mut-23*~ (with the five substitutions at patches 2 and 3) as C-terminal eGFP fusions at the endogenous locus in a W303 diploid yeast strain in which one of the chromosomal copies of *SKI7* had been deleted. To assess growth defects in the absence of *XRN1*, we used an *XRN1/xrn1Δ* diploid strain that we had previously generated ([@bib21]). After sporulation and tetrad dissection, haploids were mated accordingly to generate *ski7Δ*/*xrn1Δ*, *ski7*~Δ*exo*~*-eGFP/xrn1Δ*, *ski7ΔN/xrn1Δ*, *ski7exo*~*mut-23*~*-eGFP/*xrn1Δ, and *SKI7-eGFP*/*xrn1Δ* strains ([Figure 2](#fig2){ref-type="fig"}G; [Table S1](#mmc1){ref-type="supplementary-material"}). Consistent with previous reports, disruption of *SKI7* and *XRN1* was synthetically lethal (*ski7Δ*/*xrn1Δ*, [Figure 2](#fig2){ref-type="fig"}G) ([@bib52]). In the *ski7*~Δ*exo*~*-eGFP/xrn1Δ*, *ski7ΔN/xrn1Δ* and *ski7*~*mut-23*~*-eGFP/xrn1*Δ strain, the mutant proteins were expressed at levels comparable to wild-type Ski7-eGFP as judged by western blot ([Figure S4](#mmc1){ref-type="supplementary-material"}B), but cells showed synthetic growth defects ([Figure 2](#fig2){ref-type="fig"}G). These data are consistent with the notion that the high-affinity interactions between yeast Ski7 and the exosome are important for function in vivo.

Ski7 and Rrp6 Share a Common Interaction Surface on the Exosome Core {#sec2.6}
--------------------------------------------------------------------

We analyzed the Ski7-bound and Rrp6-bound structures to compare how the cytoplasmic and nuclear cofactors recognize the core complex. Ski7~exo~ and the C-terminal exosome-binding domain of Rrp6 (Rrp6~C~ or Rrp6~exo~) do not share apparent similarity at the sequence level ([Figure 3](#fig3){ref-type="fig"}A). However, they adopt a similar topology of secondary structure elements and engage analogous surfaces of Csl4, Mtr3, and Rrp43 ([Figure 3](#fig3){ref-type="fig"}A). In particular, Ski7~exo~ and Rrp6~exo~ bind at the patch 1 and patch 2 surfaces of the exosome with remarkably similar interactions ([Figure 3](#fig3){ref-type="fig"}B). For example, Phe549^Rrp6^ and Trp125^Ski7^ occupy the equivalent position at patch 1, and Leu572^Rrp6^ and Phe151^Ski7^ occupy the same position at patch 2 ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). After patch 2, the mode of interaction diverges. In the case of Rrp6~exo~, the polypeptide chain folds into a β-hairpin that extends toward the outer surface of Rrp43, as it does not have structural elements equivalent to Ski7~exo~ helices α3 and α4 ([Figure 3](#fig3){ref-type="fig"}A).

We evaluated the similarities and differences of Ski7 and Rrp6 binding on the exosome surface. Csl4 provides an important anchoring point for both cofactors ([Figure 3](#fig3){ref-type="fig"}B). Indeed, in vitro pull-down assays with GFP-tagged Ski7~exo~ or GFP-tagged Rrp6~exo~ showed that neither the cytoplasmic nor the nuclear cofactor coprecipitated with an exosome complex lacking Csl4 (Exo~ΔCsl4~) ([Figure 3](#fig3){ref-type="fig"}C, lanes 6 and 9, respectively). The C-terminal domain of Csl4 is involved more specifically in the interaction with Ski7 ([Figure 3](#fig3){ref-type="fig"}B). Consistently, in the *ski4-1* allele, a single-point mutation (Gly253Glu) in the C-terminal domain of Csl4 has been shown to severely reduce the association with Ski7 in vivo ([@bib53]) and to affect mRNA turnover ([@bib52]). Conversely, the structural analysis indicates that a surface of Rrp43 is involved in the interaction with Rrp6, but not with Ski7 ([Figures 3](#fig3){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}C). We engineered an Rrp43 mutant with three substitutions at this surface (Leu37Asp^Rrp43^, Ile39Asp^Rrp43^, Leu43Asp^Rrp43^, or Rrp43~mut~ mutant) ([Figures 3](#fig3){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}C), reconstituted the corresponding exosome complex (Exo~9,Rrp43-mut~), and tested it in pull-down assays with GFP-tagged Rrp6~exo~ or GFP-tagged Ski7~exo~. In these assays, the interaction of the mutant exosome with the nuclear cofactor was strongly reduced, while the cytoplasmic cofactor was not significantly affected ([Figure 3](#fig3){ref-type="fig"}C, lanes 5 and 8, respectively).

Given the overlapping binding sites of Ski7 and Rrp6, we assessed their competition for exosome binding. In devising the pull-down assays, we took into account the high affinity with which Exo~9~ binds not only Ski7~exo~ (*K*~d~ ∼5 nM, [Figure S4](#mmc1){ref-type="supplementary-material"}) but also Rrp6~exo~ (*K*~d~ ∼10 nM, [Figure S4](#mmc1){ref-type="supplementary-material"}). We preincubated Exo~9~ with either Ski7~exo~ or Rrp6~exo~ and then added the corresponding GFP-tagged competitor (GFP-Rrp6~exo~ or GFP-Ski7~exo~, respectively). In the GFP pull-down assays, GFP-Rrp6~exo~ was not able to displace bound Ski7~exo~ from the complex ([Figure 3](#fig3){ref-type="fig"}D, lane 3), while GFP-Ski7~exo~ could partially displace Rrp6~exo~ ([Figure 3](#fig3){ref-type="fig"}D, lane 5), in line with the slightly higher exosome-binding affinity of Ski7~exo~ than Rrp6~exo~ ([Figure S4](#mmc1){ref-type="supplementary-material"}A). We then reversed the order of events by incubating Exo~9~ with the GFP-tagged component first, before adding the untagged competitor. In the GFP pull-down assays, none of the untagged components could displace the tagged competitor ([Figure 3](#fig3){ref-type="fig"}D, lanes 2 and 4). We concluded that Ski7~exo~ and Rrp6~exo~ have similar and mutually exclusive binding surfaces on the exosome and that detailed differences in these interfaces can be exploited to selectively dissociate the cofactors from the complex.

HBS1-like Isoform 3 Is a Human Ski7-like Protein {#sec2.7}
------------------------------------------------

The identification of the exosome-binding residues in Ski7 prompted us to search for the long sought-after ortholog in human cells. In *L. kluyveri* and other fungi that split off from the *S. cerevisiae* branch before genome duplication, a single gene (*HBS1/SKI7*) gives rise to separate Hbs1-like and Ski7-like proteins by alternative splicing ([@bib36]). Interestingly, human HBS1 has been shown to coimmunoprecipitate with human DIS3L and SKI2W in HeLa cells ([@bib41]), but the caveat from these experiments is that the interactions could be indirect.

From the analysis of the NCBI RefSeq sequences, three splice variants are generated from a single *HBS1* gene in human cells ([Figure 4](#fig4){ref-type="fig"}A). All three HBS1-Like (HBS1L) isoforms share a similar N-terminal region, encoded by exons 1, 2, and 4. While isoforms 1 and 3 also share the region encoded by exon 3 (residues 37--78), this exon is skipped in isoform 2. The major difference, however, lies in the C-terminal domain. In isoforms 1 and 2 the C-terminal domain is a GTPase-like fold that binds the protein DOM34 ([@bib41]) and that is encoded by skipping exon 5 and starting from exon 6 (to 19). In contrast, isoform 3 contains an unrelated C-terminal domain that is encoded by exon 5 (residues 144--632). Bioinformatic analyses revealed a similarity between the yeast Ski7~exo~ domain and a C-terminal segment of HBS1-like isoform 3 (HBS1L3) (residues 540--632) ([Figure 4](#fig4){ref-type="fig"}B). In particular, several residues that mediate the interaction of Ski7 with the patch 1, patch 2, and patch 4 surfaces of the exosome appeared to be conserved in HBS1L3. This analysis suggested the HBS1L3 might bind the human exosome analogously to how Ski7 binds the yeast exosome. We tested this hypothesis using in vitro pull-down assays with purified proteins. We reconstituted human Exo~9~ and found that indeed it coprecipitated with the GFP-tagged C-terminal segment of human HBS1L3 (HBS1L3~exo~) ([Figure 4](#fig4){ref-type="fig"}C, lane 4) and not with GFP-tagged Mtr4^ΔN80ΔSK^ ([@bib18]), which was used as negative control. We concluded that HBS1L3 is a human Ski7-like protein in human that is capable of interacting with the human exosome.

Conclusions {#sec2.8}
-----------

The "Superkiller" *SKI* genes were all originally identified from mutations resulting in the overexpression of a killer toxin in virus-infected yeast strains ([@bib50]). Two decades later, it has become clear that Ski2, Ski3, and Ski8 form an obligate protein complex in vivo and that Ski7 is not stably associated with it ([@bib7]). However, Ski7 consistently coimmunoprecipitates and copurifies with endogenous exosome subunits ([@bib15], [@bib53]). Indeed, the interaction of Ski7 with exosome subunits is even more salt resistant than that of Rrp44, an intrinsic subunit of the *S. cerevisiae* core complex ([@bib15]). Our data support the notion that Ski7 is a constitutively bound component of the cytoplasmic yeast exosome: its N-terminal domain binds with low nanomolar affinity in vitro and engages the outer surfaces of the exosome rings with strong interactions. Indeed, impairing a single interaction hotspot is not sufficient to abrogate binding: the concomitant mutation of two interaction hotspots is required to impair binding in vitro and in vivo. Interestingly, the nature of the interactions of the cytoplasmic exosome-Ski7 complex is very similar to that of the nuclear exosome-Rrp6 complex. The similarities in the structures were unexpected, as Ski7 and Rrp6 do not share noticeable homology at the sequence level. Thus, Ski7 and Rrp6 appear to have evolved to exploit the same surface features of the exosome core. We speculate that the mutually exclusive interaction of Ski7 and Rrp6 with the exosome physically separates the binding to the two cofactors and potentially prevents Ski7 from being transported into to the nucleus with Rrp6-bound exosome complexes.

The N-terminal domain of yeast Ski7 does not share noticeable sequence homology with human proteins. Yet, the interacting surfaces on the yeast exosome are conserved in higher eukaryotes. Combining structural information with bioinformatic analysis, we identified the C-terminal domain of human HBS1L3 as a Ski7-like exosome-binding region. HBS1L3 also appears to contain regions with sparse sequence similarity to the Ski-complex-binding domain of yeast Ski7, but future structural studies will be required to understand the molecular mechanisms with which Ski7-like cofactors recognize and recruit the Ski complex. In contrast to the general importance of the exosome-binding and Ski-binding regions of Ski7, the C-terminal translational GTPase-like domain is required solely for the yeast NSD pathway ([@bib4], [@bib53]). HBS1L3 clearly lacks an analogous GTPase-like domain. This domain is instead present in human HBS1L1 and HBS1L2 as well as in yeast Hbs1, whereby it functions in the release of stalled ribosomes in the NGD pathway ([@bib5], [@bib20], [@bib37]; reviewed in [@bib48]). Our results thus raise a set of questions on whether the different human HBS1L isoforms might have acquired specific roles in mRNA turnover and surveillance. Understanding their detailed functions in the decay of different mRNAs in human cells is an important quest for future studies, not least because of the involvement of cytoplasmic exosome cofactors in human diseases and in the modulation of the immune system (reviewed in [@bib17], [@bib40]).

Experimental Procedures {#sec3}
=======================

Expression and Purification {#sec3.1}
---------------------------

*S. cerevisiae* Exo~9~ subunits, Rrp44 (1--1,001, D171N, D551N) and Rrp6~exo~ (518--693) were expressed in *E. coli* and purified with similar protocols as described before ([@bib6], [@bib34]). All Ski7 constructs were expressed in *E. coli* as a fusion protein with an N-terminal His tag and either a thioredoxin polypeptide cleavable with prescission protease (for structural studies) or GFP (for biochemical studies). Ski7 was purified by affinity chromatography followed by ion exchange (heparin column) and size-exclusion chromatography (SEC). The *S. cerevisiae* Exo10 complex was reconstituted as described before ([@bib6], [@bib34]), and after addition of 1.2× molar excess of Ski7 another size-exclusion chromatography was performed on a Superose 6 column (GE Healthcare). *H. sapiens* Exo~9~ proteins were expressed and purified similarly to the protocols previously described ([@bib19]). C-terminally GFP-tagged human HBS1L3~exo~ (comprising residues 540--632) was purified via Ni-affinity and after prescission protease aided cleavage of a his-thioredoxin tag, reversely passed through an Ni-affinity column, and subjected to SEC. Detailed protocols are in the [Supplemental Information](#app3){ref-type="sec"}.

Crystallization and Structure Determination {#sec3.2}
-------------------------------------------

Exo~10~--Ski7 crystallized at a concentration of 12.5 mg/ml upon the addition of 1.3× molar excess of a stem-loop RNA with sequence CCCCCGAGAGGGGG(U)~27~A (U~loop-28~). The complex (in 20 mM HEPES \[pH 7.5\], 100 mM NaCl, 2 mM MgCl~2~, and 5 mM TCEP) crystallized in 27% 2-Methyl-2,4-pentanediol (MPD), 0.1 M 2-(*N*-morpholino)ethanesulfonic acid (MES) (pH 6), and 10 mM CaCl~2~. Crystals grew typically within 10 days and were cryo-protected (in 32% MPD, 0.1 M MES \[pH 6\]) and flash-cooled in liquid nitrogen before X-ray exposure. All X-ray diffraction data were collected at 100 K at the Swiss Light Source (SLS) synchrotron in Villigen (Switzerland). The data were processed and scaled with XDS ([@bib25]). The crystals belong to the space group *P*2~1~2~1~2~1~ and contain one complex in the asymmetric unit. The data processing statistics are summarized in [Table 1](#tbl1){ref-type="table"}. The atomic model of Exo~9~ (4ifd) was used as a molecular replacement model in PHASER ([@bib38]). The single domains of Rrp44 and the visible T4L moiety were placed partly manually (as rigid bodies) and partly automatically (by PHASER runs with the fixed refined model). Manual model building with COOT ([@bib16]) was aided by models resulting from automated model building with BUCCANEER ([@bib11]). The refinement was performed with Phenix Refine ([@bib1]), and the stereochemistry was assessed by MolProbity ([@bib12]). Interface area calculations were done with the PISA server ([@bib28]). PyMOL was used for producing the figures ([@bib44]).

Pull-Down Experiments {#sec3.3}
---------------------

A total of 5 μg of tagged bait was incubated with 1.2× molar excess of untagged prey to pull down in a volume of 50 μl of pull-down buffer (20 mM Tris \[pH 7.5\], 100 mM NaCl, 0.01% NP40, 2 mM DTT). After incubation with GSH Sepharose (GE Healthcare) or GFP-binder resin, respectively, and three washing steps with pull-down buffer the resin was dried and taken up in SDS buffer. Input and pull-down fractions were analyzed on denaturing 12% SDS-PAGE.

Microscale Thermophoresis {#sec3.4}
-------------------------

For affinity measurements, Exo~9~ (no Rrp44 subunit) was buffered in 20 mM HEPES (pH 7.5), 100 mM NaCl, 2.5 mM MgCl~2~. GFP-tagged protein constructs were diluted in MST (microscale thermophoresis) buffer (20 mM HEPES \[pH 7.5\], 100 mM NaCl, 2.5 mM MgCl~2~, 0.2% Tween 20, 1 mg/ml BSA). A dilution series of Exo~9~ was produced and supplemented with even amounts of GFP-tagged protein (4--5 nM for WT Ski7 and Rrp6 constructs, 25 nM for the mutant Ski7). Different constructs were chosen due to difficult behavior of the highly hydrophobic Ski7 peptide. Thermophoresis was measured at 87%--90% LED power for Rrp6 and Ski7 WT and 20% LED power for the Ski7 mutant with standard parameters in a NanoTemper Monolith NT.115 machine. The data were analyzed with the MO software (NanoTemper Technologies), choosing a cold region between −1 and 0 and a hot region including the time range of 5 to 7 s as indicated in [Figure S3](#mmc1){ref-type="supplementary-material"}.

Yeast Experiments {#sec3.5}
-----------------

See [Supplemental Information](#app3){ref-type="sec"}.
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![The Atomic Structure of a S. *cerevisiae* Exo~10~--Ski7~exo~--RNA Complex\
(A) The overall domain structure of Ski7 is shown on top, together with its binding partners. The region of the molecule in the present structure (Ski7~exo~) is shown in teal. At the bottom is a zoom-in view with the secondary structure elements of Ski7~exo~ followed by the C-terminal T4 lysozyme (T4L). The main exosome-binding patches of Ski7~exo~ are annotated together with the Exo~9~ subunits they bind to.\
(B) Overview of the structure of Exo~10~--Ski7~exo~--RNA. Cartoon representation of the exosome with Rrp44 in light pink (Rrp44 PIN domain in violet), Csl4, Rrp4, and Rrp40 in yellow, orange, and champagne, respectively; the RNase PH ring in gray; and RNA in black. Ski7~exo~T4L is shown with Ski7~exo~ in teal and T4L in light teal.\
(C--E) Zoom-in views of three portions of the structure that are indicated in boxes in (B). Representation and colors are as in [Figure 1](#fig1){ref-type="fig"}B. RNA is in stick representation. Electron density 2F~o~--F~c~ map is shown in blue mesh around the RNA (contoured at 0.9 σ). See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Ski7 Binds the Exosome with an Extensive Interaction Network\
(A) The exosome is shown in a surface representation and Ski7~exo~T4L in cartoon representation. Colors are as in [Figure 1](#fig1){ref-type="fig"}B, except for Mtr3 (pale blue) and Rrp43 (pale orange).\
(B--D). Zoom-in views of the interaction patches 1--4 in cartoon representation, with colors as in [Figure 2](#fig2){ref-type="fig"}A. Interacting residues are in stick representation as indicated.\
(F) Protein coprecipitations in GFP pull-down assays. The exosome coprecipitates with double or triple mutants of GFP-Ski7 in a single binding patch (lanes 8--11). Only when combining mutants of two patches (Ski7^exo,exomut-23^, lane 12) the interaction lost. See also [Figure S3](#mmc1){ref-type="supplementary-material"}D.\
(G) Growth assay of wild-type and mutant yeast strains. Endogenous *SKI7* was replaced by wild-type or mutant *SKI7*-*EGFP* fusions in a strain where endogenous *XRN1* was present (left panel) or deleted (right panel). All strains (except wild-type) also carried an YCplac33\[*XRN1,URA3*\] rescue vector. For the growth assay, cells were grown to early exponential phase and spotted in serial dilutions onto 5-fluoroorotic acid (5-FOA) medium or control plates. Medium containing 5-FOA selects for cells that have lost the YCplac33\[*XRN1,URA3*\] rescue vector. Deletions of either Ski7~exo~ (row 7) or Ski7~N~ (row 8) as well as the Ski7^exo,exomut-23^ mutant (row 6) had a lethal effect. Controls: SC w/o URA, presence of rescue shuffle vector carrying *wt XRN1*; YPAD, general growth control on nonselective/permissive media; YPAD/G418, maker associated with Ski7 genomic integration; YPAD/Nat marker associated with *XRN1* knockout. For expression controls and yeast strains, see [Figure S3](#mmc1){ref-type="supplementary-material"}E and [Table S1](#mmc1){ref-type="supplementary-material"}. SC, synthetic complete medium; URA, uracil. See also [Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Ski7 and Rrp6 Share Similar Exosome-Binding Surfaces\
(A) Topology-based sequence alignment of Rrp6~exo~ and Ski7~exo~. Structural elements of Rrp6 are in red and of Ski7 in teal. Residues not visible in the Ski7 structure are in gray. The corresponding exosome-interacting proteins are annotated.\
(B) Comparison of Ski7 and Rrp6 binding to the exosome. Top view on the superposition of the nuclear (PDB: [5c0w](pdb:5c0w){#intref0020}) and cytosolic exosome (superposition based on Mtr3, yielding an optimal fit for Ski7~exo~ and Rrp6~exo)~. The cytosolic exosome is shown in surface representation with colors as in [Figure 2](#fig2){ref-type="fig"}A. The Rrp43 surface residues mutated in Exo~9,Rrp43-mut~ are in pale red. Ski7 and Rrp6 are displayed in cartoon representation. Rrp6 is in red. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.\
(C) Pull-down of mutant exosomes on GFP-Ski7 or GFP-Rrp6, respectively. SDS PAGE of a GFP-binder pull-down experiment. Mutation of a hydrophobic patch on Rrp43 does not alter the interaction with Ski7 but weakens binding of Rrp6 (lanes 5 and 8, respectively). Neither Ski7 nor Rrp6 coprecipitates with an exosome lacking Csl4 (Exo~ΔCsl4~) (lanes 6 and 9).\
(D) Competition of Ski7 and Rrp6 binding to the exosome. SDS PAGE of a GFP-binder pull-down experiment. Tagged (1×) and nontagged (4× molar ratio) Ski7 (GFP-Ski7~exo~ and Ski7~N~) and Rrp6~exo~ (GFP-Sumo-Rrp6~C~ and Sumo-Rrp6~C~) constructs were incubated with 1.2× molar excess of exosome complex. Reaction components that are annotated with a box were added 20 min after nonboxed components and before incubation with GFP-binder resin. Rrp6 does not displace bound Ski7 (lane 3), while Ski7 can partially displace Rrp6 (lane 5).](gr3){#fig3}

![HBS1-Like Isoform 3 Is a Human Ski7-like Protein\
(A) Exon-intron structure of human HBS1L. The three verified isoforms are shown. The exosome-binding region (exon 5) and the translational GTPase-like domain (exons 7--13) are indicated in teal and blue, respectively.\
(B) Multiple sequence alignment of the exosome-binding region of Ski7 from *S. cerevisiae* and the exosome-binding isoform HBS1L3 from different vertebrates. Structural elements of *Sc*. Ski7 are indicated in teal; conserved residues between Ski7 and HBS1L family members are highlighted in yellow. Abbreviations and accession numbers are as follows: Hs, *Homo sapiens*, [NP_001138679](ncbi-p:NP_001138679){#intref0025}; Mm, *Mus musculus*, [NP_001138681](ncbi-p:NP_001138681){#intref0030}; Xt, *Xenopus tropicalis*, [XP_012818244](ncbi-p:XP_012818244){#intref0035}; Tr, *Takifugu rubripes*, [XP_011610307](ncbi-p:XP_011610307){#intref0040}; Sc, *Saccharomyces cerevisiae*, [NP_014719](ncbi-p:NP_014719){#intref0045}; Sk, *Saccharomyces kudriavzevii*, EJT42305; Sa, *Saccharomyces arboricola*, EJS41691; and Se, *Saccharomyces eubayanus*, KOG96583.\
(B) Pull-down assay of human exosome with GFP-tagged C terminus of HBS1L3. SDS PAGE of a GFP-binder pull-down experiment. GFP-tagged Mtr4^ΔN80ΔSK^ ([@bib18]) was used as negative control.](gr4){#fig4}

###### 

X-Ray Data Collection and Refinement Statistics

  Dataset                     Exo~10~-Ski7-RNA
  --------------------------- --------------------------------
  Wavelength (Å)              0.97852
  Resolution range (Å)        66.69--2.65 (2.75--2.65)
  Space group                 P 2~1~2~1~2~1~
  a, b, c (Å)                 106.08, 182.53, 250.55
  α, β, γ (°)                 90, 90, 90
  Total reflections           2,802,181 (233,628)
  Unique reflections          272,923 (28,614)
  Multiplicity                10.26 (8.16)
  Completeness (%)            100.0 (99.9)
  Mean I/sigma (I)            7.33 (1.14)
  R~merge~ (%)                21.1 (176.2)
  CC(1/2)                     99.0 (36.2)
                              
  **Refinement**              
                              
  R work (%)                  21.52 (33.39)
  R free (%)                  25.86 (36.24)
  Protein residues            3,446
  RNA residues                27
  Ligands                     7 × MPD, 1 × Zn^2+^, 4 × Na^+^
  Water                       134
                              
  **Stereochemistry**         
                              
  Rms (bonds)                 0.004
  Rms (angles)                0.77
  Ramachandran favored (%)    97
  Ramachandran outliers (%)   0.27

Values for the highest-resolution shell are given in parentheses. MPD, 2-Methyl-2,4-pentanediol. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.
